Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2021 Earnings Conference Call May 5, 2021 5:30 PM ET Company Participants Mary Jenkins - IR Douglas Ingram - President, CEO & Director Ian Estepan - EVP & CFO Dallan Murray - SVP & Chief Commercial Officer Gilmore O'Neill - EVP, R&D and Chief Medical Officer Louise Rodino-Klapac - EVP & Chief Scientific Officer Conference Call Participants Tazeen Ahmad - Bank of America Merrill Lynch Gil Blum - Needham & Company Colin Bristow - UBS Daniil Gataulin - Raymond James ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Cowen 41st Annual Health Care Conference March 3, 2021 2:40 PM ET Company Participants Doug Ingram - Chief Executive Officer Conference Call Participants Ritu Baral - Cowen and Company Ritu Baral Hey, everyone. Thanks for joining us at the Sarepta fireside chat at the Cowen 2021 Health Care Conference. Hopefully, our first and only virtual health care conference for Cowen. With us from Sarepta, we have CEO, Doug Ingram; CFO, Ian Estepan; and CMO, Gilmore O'Neill, who ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2020 Earnings Conference Call March 1, 2021 4:30 AM ET Corporate Participants Mary Jenkins - Senior Manager, Investor Relations 2Doug Ingram - President and Chief Executive Officer Ian Estepan - SVP, Chief of Staff and Corporate Affairs Gilmore O’Neill - EVP, R&D and Chief Medical Officer Louise Rodino-Klapac - Executive Vice President, Chief Scientific Office Conference Call Participants Alethia Young - Cantor Fitzgerald Brian Abrahams - RBC Capital Markets Salve ...

Our mission continues. KAI Living with Duchenne muscular dystrophy J.P. MORGAN HEALTHCARE CONFERENCE – JANUARY 2021 ©SAREPTA THERAPEUTICS, INC. 2021. ALL RIGHTS RESERVED. 1 Armed with the most advanced science in genetic medicine, we are in a daily race to rescue lives otherwise stolen by rare disease. At Sarepta, every day is another twenty-four hours to stand up for patients, advance technology, challenge convention, and drag tomorrow into today. DOUGLAS INGRAM President and Chief Executive Officer JP Mor ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) 39th Annual JPMorgan Virtual Healthcare Conference January 11, 2021 10:00 AM ET Company Participants Doug Ingram - CEO Gilmore O'Neill - Head of R&D Louise Rodino-Klapac - Chief Scientific Officer Dallan Murray - Chief Commercial Officer Ian Estepan - CFO Conference Call Participants Anupam Rama - JPMorgan Tessa Romero - JPMorgan Anupam Rama Welcome everyone to the 39th Annual J.P. Morgan Healthcare Conference. My name is Anupam Rama. I am one of the senior biotech a ...

| --- | --- | --- | --- | |-------------------------------|-----------------------------------------------------------------------------------------------------|----------------------------------------------------------|-------| | | | | | | | | | | | | Clinical Update: MOMENTUM MultipleAscending Dose Study of SRP-5051 for Duchenne Muscular Dystrophy | | | | | | | | | DOUG INGRAM | GILMORE O'NEILL , MB, MMSC | | | | President and CEO | Executive Vice President, R&D and Chief Medical Officer | | | | December ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) MOMENTUM Multiple-Ascending Dose Study of SRP-5051 for Duchenne Muscular Dystrophy Conference Call December 7, 2020 8:30 AM ET Company Participants Doug Ingram - President and Chief Executive Officer Gilmore O’Neill - Executive Vice President, R&D Conference Call Participants Salveen Richter - Goldman Sachs Tazeen Ahmad - Bank of America Gena Wang - Barclays Alethia Young - Cantor Brian Skorney - Baird Anupam Rama - JPMorgan Matthew Harrison - Morgan Stanley Tyler Va ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Evercore ISI HealthCONx Conference December 2, 2020 3:30 PM ET Company Participants Douglas Ingram - President, CEO & Director Conference Call Participants Maneka Mirchandaney - Evercore ISI Maneka Mirchandaney Great. Good afternoon, everyone. I'm Maneka Mirchandaney from the Evercore ISI biotech team. I am really pleased to be here with Sarepta. We've got Doug Ingram, who's its President and CEO; and Ian Esteban, who's SVP, Chief of Staff and Corporate Affairs. Than ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Credit Suisse 29th Annual Virtual Healthcare Conference November 9, 2020 3:30 PM ET Company Participants Doug Ingram - Chief Executive Officer Conference Call Participants Martin Auster - Credit Suisse Martin Auster This is Martin Auster. I am the lead Smid cap Biotech Analyst at Credit Suisse. Thanks for joining us at the 29th Annual Credit Suisse Healthcare Conference. I’ve got Doug Ingram, CEO, along with some members of the Sarepta Therapeutics team. Very happy ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q3 2020 Results Conference Call November 5, 2020 4:30 PM ET Company Participants Mary Jenkins - Senior Manager, IR Doug Ingram - President and CEO Ian Estepan - SVP, Chief of Staff and Corporate Affairs Dr. Gilmore OÂ'Neill - EVP, R&D and Chief Medical Officer Conference Call Participants Jack Allen - Baird Tazeen Ahmad - Bank of America Emma Nealon - Cantor Fitzgerald Anupam Rama - J.P. Morgan Gena Wang - Barclays Joseph Schwartz - SVB Leerink Colin Bristow - UBS Br ...